Anew Labs Valuation, Funding & Investors

Anew Labs is valued at $1.5B as of September 2026.

Last Anew Labs valuation

$1.5B

Seed · Sep 2026

Last Anew Labs funding round

$290M

Seed · Sep 2026

Cumulative funding Anew Labs raised

$290M

across 1 funding round

Key investors in Anew Labs

  • IDG Capital
  • HSG
  • Hillhouse Investment
  • Gaorong Capital
  • 5Y Capital
  • Boyu Capital

Anew Labs Overview

About Anew Labs

Anew Labs is a platform developer that builds artificial intelligence systems for identifying pharmaceutical compounds, such as predicting molecular shapes and designing antibodies, by combining computational work with laboratory validation targeting inflammatory diseases.


Founded

2026

HQ

ChinaShanghai

Website

anewbt.com

Status

Privately held

Customer focus

B2B

Revenue model

Services

Valuation

$1.5B (Sep 2026)

Anew Labs Valuation

Anew Labs is currently valued at $1.5B, based on its seed round in September 2026. Read the announcement ↗

The $290M round was led by 5Y Capital, Hillhouse Investment, HSG and IDG Capital, with participation from Boyu Capital, Sino Biopharmaceutical, Gaorong Capital, Primavera Capital Group and Shanghai Future Industry Fund.

Anew Labs valuation by funding round

Anew Labs valuation by funding round
DateStageValuation
Sep 2026Seed$1.5B

Anew Labs Funding History

Anew Labs has raised a total of $290M across 1 funding round.

Anew Labs funding rounds

Anew Labs funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Sep 2026Seed5Y Capital (lead); Hillhouse Investment (lead); HSG (lead); IDG Capital (lead); Boyu Capital; Sino Biopharmaceutical; Gaorong Capital; Primavera Capital Group; Shanghai Future Industry Fund$290M$1.5BByteDance completed a $290 million seed financing for Anew Labs in September 2026 at a $1.5 billion post-money valuation, with HSG, IDG Capital and Hillhouse Investment as lead investors, 5Y Capital as co-lead, and participation from Gaorong Capital, Primavera Capital Group, Boyu Capital, Shanghai Future Industry Fund and Sino Biopharmaceutical. The round followed Anew Labs’ spin-off from ByteDance and left ByteDance with a 56% stake after the transaction, positioning the business as an independently managed AI drug discovery company with support from a broad group of technology, venture and strategic life-sciences backers. Anew Labs is based in Shanghai and focuses on AI-driven drug discovery and drug development, building on technology and assets developed inside ByteDance before the spin-off. The financing was described as the company’s first external fundraising and one of the largest domestic AI drug discovery rounds of 2026, reflecting investor confidence in its platform and pipeline and in the broader convergence of AI and pharmaceutical innovation.

Who has invested in Anew Labs?

9 investors have backed Anew Labs across its funding rounds, including IDG Capital, HSG, Hillhouse Investment, Gaorong Capital, 5Y Capital and Boyu Capital.

Lead investors include 5Y Capital, Hillhouse Investment, HSG and IDG Capital.


Anew Labs Investors

Investors in Anew Labs by funding rounds participated
InvestorHQRoundsRoleFirst check
Boyu CapitalChinaBeijing1ParticipantSep 2026
Sino BiopharmaceuticalHong KongHong Kong1ParticipantSep 2026
IDG CapitalHong KongHong Kong1LeadSep 2026
Gaorong CapitalChinaBeijing1ParticipantSep 2026
Hillhouse InvestmentChinaBeijing1LeadSep 2026
Primavera Capital GroupChinaBeijing1ParticipantSep 2026
5Y CapitalChinaChina1LeadSep 2026

This data is available for Pro users. Sign up to see all 9 Anew Labs investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Anew Labs Competitors

Anew Labs competitors include listed companies like BigBear.ai and TRS Information Technology, and private ones like Arda, Vinci, CodeRabbit and Magic.

Public and private companies comparable to Anew Labs
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
ArdaUnited StatesSan Francisco, CAPrivate--$1.5B-
VinciUnited StatesSan Francisco, CAPrivate--$1.5B-
BigBear.aiUnited StatesUnited StatesPublicly listed$128M($295M)$1.3B6.6x
CodeRabbitUnited StatesSan Francisco, CAPrivate$15M-$1.5B-
MagicUnited StatesSan Francisco, CAPrivate$147M-$1.5B10.2x
TRS Information TechnologyChinaChinaPublicly listed$77M($20M)$1.5B17.8x
Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Eton Pharmaceuticals$80M$3M18.7x10.8x466.8x31.2x
Bora Pharmaceuticals$584M$210M3.4x2.9x9.4x12.1x
Rapport Therapeutics-($124M)-62.4x(8.5x)(5.4x)
TRS Information Technology$77M($20M)17.4x17.8x(66.1x)433.4x
Ocular Therapeutix$52M($268M)19.5x19.2x(3.8x)(3.1x)
Nippon Shinyaku$1.1B$267M0.9x0.9x3.8x3.7x
Innoviva$411M$349M3.0x2.8x3.5x5.3x
Idorsia$268M($55M)11.1x10.8x(53.6x)(32.6x)

This data is available for Pro users. Sign up to see all Anew Labs competitors and their valuation data.

Start Free Trial

Common questions about Anew Labs

When was Anew Labs founded?Anew Labs was founded in 2026.
Where is Anew Labs headquartered?Anew Labs is headquartered in Shanghai, China.
Is Anew Labs publicly listed?No, Anew Labs is a private, VC-backed company.
What is Anew Labs' valuation?Anew Labs was last valued at $1.5B in its seed round in September 2026.
How much funding has Anew Labs raised?Anew Labs has raised $290M across 1 funding round.
What was Anew Labs' last funding round?Anew Labs' last funding round was a $290M seed round in September 2026, led by 5Y Capital, Hillhouse Investment, HSG and IDG Capital.
Who are Anew Labs' investors?Anew Labs' investors include Boyu Capital, Sino Biopharmaceutical, IDG Capital, Gaorong Capital, Hillhouse Investment, Primavera Capital Group, 5Y Capital, Shanghai Future Industry Fund and HSG.
Which companies are comparable to Anew Labs?Companies comparable to Anew Labs include Arda, Vinci, BigBear.ai, CodeRabbit, Magic and TRS Information Technology.

See companies similar to Anew Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial